M. Atzl

SARS-CoV-2 RBD-specific and NP-specific antibody response of healthcare workers in the westernmost Austrian state Vorarlberg: a prospective cohort study

T. Winder, P. Fraunberger, K. Geiger, 2022, BMJ Open.

SARS-CoV-2 serostatus of healthcare worker in the Austrian state Vorarlberg between June 2020 and January 2021

T. Winder, P. Fraunberger, A. Volgger, 2021, medRxiv.

A Lower CD4 Count Predicts Most Causes of Death except Cardiovascular Deaths. The Austrian HIV Cohort Study

Z. El-Khatib, B. Ledergerber, A. Rieger, 2021, International journal of environmental research and public health.

Serological SARS‐CoV‐2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID‐19 vaccine in haematological and oncological patients

H. Ulmer, T. Winder, P. Fraunberger, 2021, British journal of haematology.

HIV-triggered lymphoma

B. Hartmann, M. Atzl, 2019, memo - Magazine of European Medical Oncology.

Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID‐19 vaccine in haemato‐oncological patients with no antibody response

H. Ulmer, T. Winder, P. Fraunberger, 2021, British journal of haematology.